Hepatic passaging of NRAS-mutant melanoma influences adhesive properties and metastatic pattern
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Hepatic passaging of NRAS-mutant melanoma influences adhesive properties and metastatic pattern ; volume:23 ; number:1 ; day:13 ; month:5 ; year:2023 ; pages:1-16 ; date:12.2023
BMC cancer ; 23, Heft 1 (13.5.2023), 1-16, 12.2023
- Urheber
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12885-023-10912-4
- URN
-
urn:nbn:de:101:1-2023090812295302041078
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:49 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Dietsch, Bianca
- Weller, Céline
- Sticht, Carsten
- Torre, Carolina de la
- Kramer, Martin
- Goerdt, Sergij
- Géraud, Cyrill
- Wohlfeil, Sebastian A.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Variation of mutant allele frequency in NRAS Q61 mutated melanomas
Exploiting TERT dependency as a therapeutic strategy for NRAS-mutant melanoma
Combination of pan-RAF and MEK inhibitors in NRAS mutant melanoma
Antitumor activity of the ERK inhibitor SCH722984 against BRAF mutant, NRAS mutant and wild-type melanoma
Erratum to: Antitumor activity of the ERK inhibitor SCH722984 against BRAF mutant, NRAS mutant and wild-type melanoma
Inhibition and degradation of NRAS with a pan-NRAS monobody
Circulating tumor DNA allows early treatment monitoring in BRAF- and NRAS-mutant malignant melanoma
The lincRNA MIRAT binds to IQGAP1 and modulates the MAPK pathway in NRAS mutant melanoma
Glucose Intolerance in Liver Cirrhosis: Role of Hepatic and Non-Hepatic Influences
Current views concerning the influences of murine hepatic endothelial adhesive and cytotoxic properties on interactions between metastatic tumor cells and the liver
HSPB8 counteracts tumor activity of BRAF- and NRAS-mutant melanoma cells by modulation of RAS-prenylation and autophagy
Dynamic and unpredictable changes in mutant allele fractions of BRAF and NRAS during visceral progression of cutaneous malignant melanoma
Variation of mutant allele frequency in NRAS Q61 mutated melanomas
Exploiting TERT dependency as a therapeutic strategy for NRAS-mutant melanoma
Combination of pan-RAF and MEK inhibitors in NRAS mutant melanoma
Antitumor activity of the ERK inhibitor SCH722984 against BRAF mutant, NRAS mutant and wild-type melanoma
Erratum to: Antitumor activity of the ERK inhibitor SCH722984 against BRAF mutant, NRAS mutant and wild-type melanoma
Inhibition and degradation of NRAS with a pan-NRAS monobody
Circulating tumor DNA allows early treatment monitoring in BRAF- and NRAS-mutant malignant melanoma
The lincRNA MIRAT binds to IQGAP1 and modulates the MAPK pathway in NRAS mutant melanoma
Glucose Intolerance in Liver Cirrhosis: Role of Hepatic and Non-Hepatic Influences
Current views concerning the influences of murine hepatic endothelial adhesive and cytotoxic properties on interactions between metastatic tumor cells and the liver
HSPB8 counteracts tumor activity of BRAF- and NRAS-mutant melanoma cells by modulation of RAS-prenylation and autophagy
Dynamic and unpredictable changes in mutant allele fractions of BRAF and NRAS during visceral progression of cutaneous malignant melanoma
Variation of mutant allele frequency in NRAS Q61 mutated melanomas
Exploiting TERT dependency as a therapeutic strategy for NRAS-mutant melanoma
Combination of pan-RAF and MEK inhibitors in NRAS mutant melanoma
Antitumor activity of the ERK inhibitor SCH722984 against BRAF mutant, NRAS mutant and wild-type melanoma
Erratum to: Antitumor activity of the ERK inhibitor SCH722984 against BRAF mutant, NRAS mutant and wild-type melanoma
Inhibition and degradation of NRAS with a pan-NRAS monobody
Circulating tumor DNA allows early treatment monitoring in BRAF- and NRAS-mutant malignant melanoma
The lincRNA MIRAT binds to IQGAP1 and modulates the MAPK pathway in NRAS mutant melanoma
Glucose Intolerance in Liver Cirrhosis: Role of Hepatic and Non-Hepatic Influences
Current views concerning the influences of murine hepatic endothelial adhesive and cytotoxic properties on interactions between metastatic tumor cells and the liver
HSPB8 counteracts tumor activity of BRAF- and NRAS-mutant melanoma cells by modulation of RAS-prenylation and autophagy